Synthesis and biological analysis of benzazol-2-yl piperazine sulfonamides as 11β-hydroxysteroid dehydrogenase 1 inhibitors
…, DV Kratschmar, B Schernthanner, A Vuorinen…
Index: Hofer, Sandra; Kratschmar, Denise V.; Schernthanner, Brigitte; Vuorinen, Anna; Schuster, Daniela; Odermatt, Alex; Easmon, Johnny Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 19 p. 5397 - 5400
Full Text: HTML
Citation Number: 7
Abstract
Abstract In the last decade the inhibition of the enzyme 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) emerged as a promising new strategy to treat diabetes and several metabolic syndrome phenotypes. Using a molecular modeling approach and classical bioisosteric studies, we discovered a new class of 11β-HSD1 inhibitors bearing an arylsulfonylpiperazine scaffold. Optimization of the initial lead resulted in compound 11 ...
Related Articles:
Discovery of imidazole carboxamides as potent and selective CCK1R agonists
[Zhu, Cheng; Hansen, Alexa R.; Bateman, Thomas; Chen, Zhesheng; Holt, Tom G.; Hubert, James A.; Karanam, Bindhu V.; Lee, Susan J.; Pan, Jie; Qian, Su; Reddy, Vijay B.G.; Reitman, Marc L.; Strack, Alison M.; Tong, Vincent; Weingarth, Drew T.; Wolff, Michael S.; MacNeil, Doug J.; Weber, Ann E.; Duffy, Joseph L.; Edmondson, Scott D. Bioorganic and Medicinal Chemistry Letters, 2008 , vol. 18, # 15 p. 4393 - 4396]